🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
The purpose of this trial is to evaluate the immunogenicity, the safety and...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-06-05
Trial ID
NCT02106390
Treatments Being Tested
This study will test the effectiveness of two interventions (parent-targete...
Status
Completed
Location
University of Florida
Start Date
2021-11-18
Trial ID
NCT05006833
The purpose of this study was to assess the safety, effectiveness, and immu...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-06-14
Trial ID
NCT04886154
This is extension of the V102\_16 study (NCT02140762). V102\_16E1 is design...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-01
Trial ID
NCT02285777
Treatments Being Tested
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested
Infants aged 9 months will be randomized to receive a meningococcal vaccine...
Status
Completed
Location
Centre pour le Developpement des Vaccins du Mali
Start Date
2022-03-24
Trial ID
NCT05093829
Treatments Being Tested
The primary objective was to evaluate the persistence of bactericidal antib...
Status
Completed
Location
Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615
Start Date
2010-07
Trial ID
NCT01148017
Treatments Being Tested
The purpose/aim of this study is to assess the safety and antibody response...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-12-08
Trial ID
NCT02986854
The bacterium (germ) Neisseria meningitidis causes meningitis and blood poi...
Status
Completed
Location
Oxford Vaccine Group
Start Date
2012-12
Trial ID
NCT01593514
Treatments Being Tested